What Is Normal in the First Weeks

The first two to four weeks of a new psychiatric medication are when side effects are most prominent. This is because the body and brain are adjusting to a new chemical environment before the therapeutic effects have fully developed. Understanding this timeline is important: many patients discontinue medications in the first two weeks because side effects are present and therapeutic benefits are not yet visible — exactly the window when the side effect-to-benefit ratio is worst and most likely to improve with continued use.

SSRIs and SNRIs (sertraline, escitalopram, fluoxetine, duloxetine, venlafaxine). The most common early side effects are: nausea (taking the medication with food typically reduces this significantly; it usually resolves within one to two weeks), headache, dizziness, insomnia or vivid dreams (taking the medication in the morning reduces sleep-related effects), and agitation or jitteriness (more common with fluoxetine and venlafaxine, typically resolves with time or dose adjustment). These are expected and do not indicate a problem with the medication or that the medication is wrong for you. They represent the brain adapting to altered serotonergic/noradrenergic signaling before homeostatic adjustment occurs.

Bupropion (Wellbutrin). Common early side effects: headache, insomnia, dry mouth, and agitation. Bupropion lowers seizure threshold, which becomes clinically significant at higher doses — the dose titration schedule is structured to minimize this risk. The seizure risk at standard doses in patients without seizure risk factors is low but real; this is why the starting dose is 150 mg XL and increases to 300 mg after a week, not immediately.

Mirtazapine. Sedation is the most prominent and consistent side effect — taking it before bed uses this effect therapeutically for sleep and minimizes daytime impairment. Weight gain and increased appetite are common. The sedation typically diminishes over weeks.

Atypical antipsychotics (aripiprazole, quetiapine, olanzapine). Sedation is common, particularly with quetiapine and olanzapine. Akathisia (restlessness) is associated with aripiprazole and brexpiprazole. Metabolic effects (weight gain, glucose changes) develop over weeks to months. Constipation is common with many atypical antipsychotics. Early dizziness on standing (orthostatic hypotension) is most common with quetiapine and olanzapine and is managed by slow position changes and adequate hydration.

Mood stabilizers (lithium, valproate, lamotrigine). Lithium: fine hand tremor, polyuria (frequent urination), polydipsia (increased thirst), and GI effects early on. Valproate: GI effects (nausea, stomach upset — taking with food helps; extended-release formulations reduce this), sedation, hair thinning. Lamotrigine: mild headache and dizziness early; the rash risk (Stevens-Johnson syndrome) is the serious concern and is minimized by following the slow titration schedule.

Side Effects That Warrant Monitoring

Some side effects are not dangerous but require monitoring and discussion at follow-up appointments, as they may affect adherence, quality of life, or long-term tolerability.

Sexual side effects with SSRIs and SNRIs. Reduced libido, delayed orgasm, and erectile dysfunction are among the most common reasons patients discontinue antidepressants without telling their provider. These effects are real, common (estimated 30–60% of patients on SSRIs), and addressable. Strategies include: reducing dose if clinically possible, switching to a more sexually favorable antidepressant (bupropion, mirtazapine, or vilazodone), adding bupropion as an augmenting agent, or medication holidays on weekends (appropriate for some patients on short-acting SSRIs). Do not discontinue medication for this reason without discussing it with your provider — the problem is usually addressable without losing the antidepressant benefit.

Weight changes. Weight gain is associated with mirtazapine, paroxetine, quetiapine, olanzapine, valproate, and lithium. Weight loss is associated with bupropion and topiramate. Monitor weight monthly when starting these agents and discuss at follow-up. Weight gain is a legitimate reason to consider switching to a more weight-neutral agent if it is clinically appropriate.

Metabolic changes with atypical antipsychotics. Elevated fasting glucose, elevated lipids, and elevated HbA1c develop over months of treatment with olanzapine, quetiapine, and clozapine most prominently. Baseline and follow-up metabolic monitoring is standard of care. These changes may be asymptomatic and detected only through blood work — which is why the monitoring schedule matters.

Cognitive effects. Some patients notice cognitive dulling, word-finding difficulty, or “brain fog” on certain psychiatric medications, particularly valproate, topiramate, and high-dose quetiapine. Distinguish between cognitive effects of medication and cognitive symptoms of the underlying condition; sometimes what feels like medication-induced cognitive impairment is actually the residual cognitive symptoms of undertreated depression or anxiety. If cognitive effects are prominent and do not resolve, discuss at your next medication management visit.

When to Call (430) 288-5800

Certain side effects require immediate contact with your prescribing clinician or, in the most serious cases, emergency care.

Worsening suicidal thoughts or new emergence of suicidal ideation. The FDA black box warning on antidepressants notes an increased risk of suicidal thinking in children, adolescents, and young adults (up to age 24) in the first weeks of treatment. If suicidal ideation worsens, new suicidal thoughts emerge, or you are experiencing unusual agitation, irritability, or distressing emotional states after starting an antidepressant, contact your prescriber immediately or Call (430) 288-5800

Lamotrigine rash. Any rash developing within the first 8–12 weeks of lamotrigine treatment requires immediate contact with your prescriber. Most rashes on lamotrigine are benign, but Stevens-Johnson syndrome (SJS) is a serious, potentially life-threatening rash that begins as lamotrigine-associated rash. SJS is rare when the slow titration schedule is followed, but any rash requires prompt evaluation to determine whether it is benign or the early presentation of SJS. Do not wait and see — Call (430) 288-5800

Lithium toxicity symptoms. Symptoms of lithium toxicity include: coarse tremor (distinct from the fine tremor that is a tolerable side effect), confusion, drowsiness, incoordination, and GI symptoms (nausea, vomiting, diarrhea). If you are on lithium and experience these symptoms, contact your prescriber immediately or go to the nearest ER. Lithium toxicity can be serious and requires evaluation. Dehydration (from illness, exercise, heat exposure, or diuretic use) and NSAID use (ibuprofen, naproxen) are common causes of lithium level elevation — use these with caution and inform your prescriber.

Neuroleptic malignant syndrome (NMS). A rare but serious reaction to antipsychotic medications involving high fever, muscle rigidity, altered mental status, and autonomic instability. Requires emergency evaluation. Call (430) 288-5800

Serotonin syndrome. A potentially serious condition caused by excessive serotonergic activity, usually when multiple serotonergic medications are combined. Features: tremor, agitation, diarrhea, elevated temperature, muscle twitching, and in severe cases, high fever and seizures. If you are on multiple medications that affect serotonin and develop these symptoms, seek emergency care.

Managing Side Effects at ETX Psychiatry

Side effect management is a core component of medication management at ETX Psychiatry. We do not treat side effects as an inevitable cost of treatment or as a reason to discontinue effective medication without exploring options. Most side effects have solutions: dose adjustment, timing changes, switch to a closely related agent with a better tolerability profile, or addition of a medication specifically targeting the side effect.

The most important thing patients can do about side effects is tell their prescriber about them rather than stopping the medication unilaterally. Many patients discontinue medications for sexual side effects, weight gain, or GI problems without mentioning it at their next appointment, losing the therapeutic benefit without exploring alternatives that might have preserved both benefit and tolerability. Open communication about side effects is essential to good medication management.

We provide thorough side effect education at medication initiation and explicit guidance on what to monitor, what to contact us about, and when to go to the emergency room. Follow-up visits are structured to review both therapeutic response and side effect burden. Our goal is medication that works and that you can stay on — tolerability is not a secondary consideration.

We accept Medicare, Aetna, Blue Cross Blue Shield, Cigna/Evernorth, Optum, UnitedHealthcare, UMR, and Ambetter. Located at 100 Independence Pl, Suite 405, Tyler, TX 75703. Telehealth available. Call (430) 288-5800(430) 288-5800 or request online.